Kinnate Biopharma Inc (DELISTED) (KNTE:DL)
2.65
0.00 (0.00%)
USD |
NASDAQ |
Apr 03, 16:00
Kinnate Biopharma Total Liabilities (Quarterly): 14.28M for Dec. 31, 2023
Total Liabilities (Quarterly) Chart
Historical Total Liabilities (Quarterly) Data
| Date | Value |
|---|---|
| December 31, 2023 | 14.28M |
| September 30, 2023 | 18.29M |
| June 30, 2023 | 18.52M |
| March 31, 2023 | 21.12M |
| December 31, 2022 | 20.36M |
| September 30, 2022 | 18.79M |
| June 30, 2022 | 15.17M |
| March 31, 2022 | 17.80M |
| Date | Value |
|---|---|
| December 31, 2021 | 12.39M |
| September 30, 2021 | 10.30M |
| June 30, 2021 | 8.323M |
| March 31, 2021 | 7.793M |
| December 31, 2020 | 7.304M |
| September 30, 2020 | 6.699M |
| December 31, 2019 | 95.09M |
Total Liabilities Definition
Liabilities are a main portion of the balance sheet of a company that measure outstanding payables/obligations. A few examples of liabilties of a company include accounts payable, current debt, and capital lease obligations. From an accounting perspective, the balance sheet equation is Liabilties = Assets - Shareholder's Equity.
Total Liabilities (Quarterly) Range, Past 5 Years
6.699M
Minimum
Sep 2020
95.09M
Maximum
Dec 2019
19.48M
Average
15.17M
Median
Jun 2022
Total Liabilities (Quarterly) Benchmarks
| XOMA Corp | 137.08M |
| Societal CDMO Inc (DELISTED) | 94.81M |
| NGM Biopharmaceuticals Inc (DELISTED) | 20.23M |
| Avrobio Inc | 3.509M |
| Landos Biopharma Inc | 6.742M |
Total Liabilities (Quarterly) Related Metrics
| Total Assets (Quarterly) | 173.60M |
| Shareholders Equity (Quarterly) | 159.33M |